《新股消息》嗶哩嗶哩(09626.HK)首日招股 孖展暫錄166億超購21倍
嗶哩嗶哩(09626.HK)(BILI.US)來港第二上市首日招股,綜合9家券商數據,截至下午約6時暫為共借出近166億元孖展認購,以公開發售部分集資7.41億元計超購約21.4倍。
嗶哩嗶哩今次將在港發行2,500萬股Z類股份,每股美國存託股等同1股Z類普通股,當中3%即約75萬股在港公開發售。以最高發售價每股988元計,集資最多247億元。招股期至下周二(23日)結束,每手20股入場費約19,959.12元,將於29日上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.